Avenue Therapeutics (OTC:ATXI) reported quarterly earnings of $0.11 per share. This is a 101.71 percent increase over losses of $(6.43) per share from the same period last year. The company reported $1.404 million in sales this quarter.
Avenue Therapeutics (OTC:ATXI) reported quarterly earnings of $0.11 per share. This is a 101.71 percent increase over losses of $(6.43) per share from the same period last year. The company reported $1.404 million in sales this quarter.
Comments